Pages that link to "Q40668072"
Jump to navigation
Jump to search
The following pages link to Replication of yellow fever virus in the mouse central nervous system: comparison of neuroadapted and non-neuroadapted virus and partial sequence analysis of the neuroadapted strain (Q40668072):
Displaying 27 items.
- Changes in mumps virus gene sequence associated with variability in neurovirulent phenotype (Q24655557) (← links)
- Apoptosis in the Mouse Central Nervous System in Response to Infection with Mouse-Neurovirulent Dengue Viruses (Q27469520) (← links)
- Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE). (Q27469763) (← links)
- Neuroadapted yellow fever virus 17D: genetic and biological characterization of a highly mouse-neurovirulent virus and its infectious molecular clone (Q27469879) (← links)
- Yellow fever virus encephalitis: properties of the brain-associated T-cell response during virus clearance in normal and gamma interferon-deficient mice and requirement for CD4 lymphocytes (Q27469887) (← links)
- Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine (Q27469921) (← links)
- Attenuation of Murray Valley encephalitis virus by site-directed mutagenesis of the hinge and putative receptor-binding regions of the envelope protein (Q27469932) (← links)
- A functional epitope determinant on domain III of the Japanese encephalitis virus envelope protein interacted with neutralizing-antibody combining sites (Q27473104) (← links)
- Type- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent Epitopes (Q27485031) (← links)
- JE Nakayama/JE SA14-14-2 virus structural region intertypic viruses: Biological properties in the mouse model of neuroinvasive disease (Q27485478) (← links)
- E Protein Domain III Determinants of Yellow Fever Virus 17D Vaccine Strain Enhance Binding to Glycosaminoglycans, Impede Virus Spread, and Attenuate Virulence (Q27486116) (← links)
- Neuroadapted Yellow Fever Virus 17D: Determinants in the Envelope Protein Govern Neuroinvasiveness for SCID Mice (Q27486896) (← links)
- Neuroadapted Yellow Fever Virus Strain 17D: a Charged Locus in Domain III of the E Protein Governs Heparin Binding Activity and Neuroinvasiveness in the SCID Mouse Model (Q27487402) (← links)
- The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1 (Q27491317) (← links)
- Structural basis of a flavivirus recognized by its neutralizing antibody: solution structure of the domain III of the Japanese encephalitis virus envelope protein (Q27641947) (← links)
- The history and evolution of human dengue emergence (Q34903764) (← links)
- Molecular determinants of virulence: the structural and functional basis for flavivirus attenuation (Q35613317) (← links)
- Pathogenesis of flavivirus encephalitis (Q35613343) (← links)
- Pathogenesis and pathophysiology of yellow fever (Q35613346) (← links)
- Yellow fever vaccine (Q36238729) (← links)
- Duck Tembusu virus exhibits neurovirulence in BALB/c mice (Q37152017) (← links)
- Dynamic viral dissemination in mice infected with yellow fever virus strain 17D. (Q37254316) (← links)
- Biomarkers in Japanese encephalitis: a review (Q37425963) (← links)
- Amino acid changes within the E protein hinge region that affect dengue virus type 2 infectivity and fusion (Q39585856) (← links)
- Amino acid changes in the recombinant Dengue 3 Envelope domain III determine its antigenicity and immunogenicity in mice. (Q40476474) (← links)
- Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology (Q42991074) (← links)
- Japanese Encephalitis Virus Generated Neurovirulence, Antigenicity, and Host Immune Responses (Q58999704) (← links)